General Information
AstraZeneca D5551L00006
A Randomized, Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared with Placebo on 24-hour Glucose Control in Metformin-treated Patients with Type 2 Diabetes.
| Protocol | D5551L00006 |
|---|---|
| Identifier | D5551L00006 Site Number: E7819 |
| UID | 23178a30-6e6a-4feb-b9d9-87915349d44b |
| Status | Done - Archived |
| Phase | IV |
| Category | Diabetes Type 2 |
| Launch Year | 2014 |
| NCT Number | - |
| Created | 2014-10-07 14:09 |
| Last Updated | 2014-10-07 14:09 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2014-12-12 | No |
| PI Meeting Start | 2014-12-04 | No |
| PI Meeting End | 2014-12-05 | No |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2015-10-21 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Rocha, Luis | LRocha | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | AstraZeneca Pharmaceuticals |
|---|---|
| Division | AstraZeneca Pharamecuticals |
| Team | AstraZeneca Pharamecuticals LP |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Medpace, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
